Furthermore, the OX40/OX40L pathway typically suppresses ATLL cells with a regulatory T cell (Treg) phenotype, thereby enhancing the immune cell‐mediated tumor destruction. Here, TNFSF4 is linked to adult T-cell leukemia/lymphoma.